Ref: https://seekingalpha.com
Amgen (AMGN) and Five Prime Therapeutics (FPRX) ink fusion agreement whereby AMGN will acquire Five Prime for $ 38.00 / share in cash, which equates to an equity value of ...
CAMEROON MAGAZINE - GM04/03/20211 Mins read85 ViewsRef: https://seekingalpha.com
The revised submission from Ark now includes risks of a change to...
ByCAMEROON MAGAZINE - GM16/10/2023A pair of exchange-traded funds managed by Cathie Wood's ARK Investment sold...
ByCAMEROON MAGAZINE - GM11/08/2023The deal was a bid to strengthen Amgen's drug portfolio as it...
ByCAMEROON MAGAZINE - GM16/05/2023Cathie Wood d’Ark Investment Management croit en l’achat de la baisse :...
ByCAMEROON MAGAZINE - GM06/12/2021